Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$208M |
| 2 |
Lowe's Companies
LOW
|
+$198M |
| 3 |
American Tower
AMT
|
+$161M |
| 4 |
Lennar Class A
LEN
|
+$150M |
| 5 |
British American Tobacco
BTI
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$208M |
| 2 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$177M |
| 3 |
Crown Castle
CCI
|
+$168M |
| 4 |
Walmart Inc
WMT
|
+$167M |
| 5 |
Entergy
ETR
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.75% |
| 2 | Technology | 13.18% |
| 3 | Healthcare | 11.51% |
| 4 | Industrials | 10.45% |
| 5 | Consumer Discretionary | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Cenovus Energy
CVE
$58.3B
| $9.6M | 0.01% |
957,718
-498,276
| -34% | -$4.08M |
|
1277
Columbia Banking Systems
COLB
$8.64B
| $9.59M | 0.01% |
227,808
+25,029
| +12% | +$968K |
|
|
CBIO
1278
Crescent Biopharma
CBIO
$642M
| $9.58M | 0.01% |
6,850
-6,919
| -50% | -$8.12M |
|
|
TUP
1279
DELISTED
Tupperware Brands Corporation
TUP
| $9.56M | 0.01% |
154,721
-75,190
| -33% | -$4.64M |
|
1280
OR Royalties Inc
OR
$7.22B
| $9.56M | 0.01% |
740,708
-768,398
| -51% | -$9.94M |
|
1281
SiriusXM
SIRI
$9.78B
| $9.54M | 0.01% |
172,917
+168,743
| +4,043% | +$9.34M |
|
1282
Energy Recovery
ERII
$400M
| $9.54M | 0.01% |
1,207,986
-553,475
| -31% | -$3.95M |
|
1283
Virtus Investment Partners
VRTS
$1.11B
| $9.52M | 0.01% |
+82,030
| New | +$9.16M |
|
|
INST
1284
DELISTED
Instructure, Inc.
INST
| $9.52M | 0.01% |
287,065
+190,480
| +197% | +$5.88M |
|
1285
Mitsubishi UFJ Financial
MUFG
$250B
| $9.5M | 0.01% |
1,475,709
+977,356
| +196% | +$6.17M |
|
1286
Gibraltar Industries
ROCK
$1.37B
| $9.5M | 0.01% |
305,102
+284,304
| +1,367% | +$8.58M |
|
1287
Phibro Animal Health
PAHC
$1.44B
| $9.47M | 0.01% |
255,574
+90,153
| +54% | +$3.39M |
|
|
SIVB
1288
DELISTED
SVB Financial Group
SIVB
| $9.46M | 0.01% |
50,573
-27,078
| -35% | -$4.76M |
|
1289
Par Pacific Holdings
PARR
$3.75B
| $9.44M | 0.01% |
454,032
+399,972
| +740% | +$7.25M |
|
1290
Toll Brothers
TOL
$13.7B
| $9.39M | 0.01% |
226,399
-3,162,733
| -93% | -$124M |
|
1291
Telefônica Brasil
VIV
$18.4B
| $9.38M | 0.01% |
592,392
-162,088
| -21% | -$2.46M |
|
1292
CALL
Zimmer Biomet
ZBH
$19B
| $9.37M | 0.01% |
82,400
+30,900
| +60% | +$3.57M |
|
1293
Fair Isaac
FICO
$24.8B
| $9.29M | 0.01% |
+66,118
| New | +$9.26M |
|
1294
VeriSign
VRSN
$26.4B
| $9.27M | 0.01% |
87,160
+49,794
| +133% | +$5.01M |
|
|
CBI
1295
DELISTED
Chicago Bridge & Iron Nv
CBI
| $9.27M | 0.01% |
551,897
-1,449,149
| -72% | -$22.2M |
|
|
TAHO
1296
DELISTED
Tahoe Resources Inc
TAHO
| $9.26M | 0.01% |
1,756,788
+1,589,706
| +951% | +$8.65M |
|
1297
MillerKnoll
MLKN
$1.57B
| $9.25M | 0.01% |
257,775
+183,483
| +247% | +$6.17M |
|
1298
Gildan
GIL
$10.1B
| $9.25M | 0.01% |
+295,574
| New | +$9.05M |
|
1299
M&T Bank
MTB
$34.7B
| $9.24M | 0.01% |
57,351
-300,295
| -84% | -$47.2M |
|
|
RARX
1300
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $9.22M | 0.01% |
631,757
+434,042
| +220% | +$6.56M |
|
Similar funds
Israel Englander's Q3 2017 Portfolio in Review
As of Q3 2017, Israel Englander held 4,198 positions worth $65.6B, up 17% from $56.1B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.
Israel Englander deployed $6.37B of net new capital in Q3 2017, opening 794 new positions and adding to 1,441 existing holdings. Its largest new stake was Northern Trust: 1,591,041 shares worth $146M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $208M trimmed.
- Israel Englander's largest Q3 2017 buy was Northern Trust: 1,591,041 shares worth $146M.
- Israel Englander added most to Salesforce in Q3 2017, an estimated $208M increase.
- Israel Englander's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $208M.
- Israel Englander fully exited CONCHO RESOURCES INC. in Q3 2017, selling an estimated $177M.
- Israel Englander's ten largest holdings make up 7.8% of its $65.6B portfolio in Q3 2017.
- Israel Englander opened 794 new positions and closed 737 in Q3 2017.
- Israel Englander's portfolio value rose 17% quarter-over-quarter to $65.6B.
Based on Millennium Management's 13F filing for Q3 2017, filed 14 Nov 2017.